Autor: "Macías J" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection.
Autorzy:: Fernandez-Fuertes M; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Sevilla, 41014, Spain.
Macías J; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Sevilla, 41014, Spain. .
Corma-Gómez A; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Sevilla, 41014, Spain.
Rincón P; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Sevilla, 41014, Spain.
Merchante N; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Sevilla, 41014, Spain.
Gómez-Mateos J; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Sevilla, 41014, Spain.
Pineda JA; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Sevilla, 41014, Spain.
Real LM; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Sevilla, 41014, Spain.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2020 Apr 21; Vol. 10 (1), pp. 6736. Date of Electronic Publication: 2020 Apr 21.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Fatty Liver/*epidemiology
HIV/*pathogenicity
HIV Infections/*epidemiology
Hepacivirus/*pathogenicity
Hepatitis C, Chronic/*epidemiology
Liver/*pathology
Body Mass Index ; Cholesterol, HDL/blood ; Cholesterol, LDL/blood ; Coinfection ; Cross-Sectional Studies ; Elasticity Imaging Techniques ; Fatty Liver/diagnostic imaging ; Fatty Liver/pathology ; Fatty Liver/virology ; Female ; HIV/growth & development ; HIV Infections/diagnostic imaging ; HIV Infections/pathology ; HIV Infections/virology ; Hepacivirus/growth & development ; Hepatitis C, Chronic/diagnostic imaging ; Hepatitis C, Chronic/pathology ; Hepatitis C, Chronic/virology ; Humans ; Liver/diagnostic imaging ; Liver/virology ; Male ; Middle Aged ; Prevalence ; Retrospective Studies ; Risk Factors ; Spain/epidemiology ; Triglycerides/blood

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort.
Autorzy:: Pérez AB; Clinical Microbiology Unit, University Hospital Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Chueca N; Clinical Microbiology Unit, University Hospital San Cecilio, Instituto de Investigacion Ibs. Granada, Granada, Spain.
Macías J; Infectious Diseases Unit, University Hospital Nuestra Señora de Valme, Sevilla, Spain.
Pineda JA; Infectious Diseases Unit, University Hospital Nuestra Señora de Valme, Sevilla, Spain.
Salmerón J; Hepatology Unit, University Hospital San Cecilio Granada, Instituto de Investigación Ibs. CIBERehd, Granada, Spain.
Rivero-Juárez A; Infectious Diseases Unit, University Hospital Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba, Spain.
Hidalgo-Tenorio C; Infectious Diseases Unit, University Hospital Virgen de las Nieves, Granada, Spain.
Espinosa MD; Hepatology Unit, University Hospital Virgen de las Nieves, Granada, Spain.
Téllez F; Infectious Diseases Unit, Hospital Puerto Real, Puerto Real, Cádiz, Spain.
Von-Wichmann MÁ; Infectious Diseases Unit, University Hospital Donostia, San Sebastián, Spain.
Omar M; Infectious Diseases Unit, Complejo Hospitalario de Jaén, Jáen, Spain.
Santos J; Infectious Diseases Unit, University Hospital Virgen de la Victoria, Málaga, Spain.
Hernández-Quero J; Infectious Diseases Unit, University Hospital San Cecilio, Granada, Spain.
Antón JJ; Penitenciary Physician, Albolote Penitenciary, Albolote, Granada, Spain.
Collado A; Infectious Diseases Unit, Complejo Hospitalario Torrecárdenas, Almería, Spain.
Lozano AB; Infectious Diseases Unit, Hospital de Poniente, El Ejido, Almería, Spain.
García-Deltoro M; Infectious Diseases Unit, Hospital General de Valencia, Valencia, Spain.
Casado M; Hepatology Unit, Complejo Hospitalario Torrecárdenas, Almería, Spain.
Pascasio JM; Hepatology Unit, University Hospital Virgen del Rocío, Seville, Spain.
Selfa A; Hepatology Unit, Hospital Comarcal Santa Ana, Motril Granada, Spain.
Rosales JM; Hepatology Unit, Hospital Costa del Sol, Marbella, Málaga, Spain.
De la Iglesia A; Clinical Microbiology Unit, University Hospital Infanta Elena, Huelva, Spain.
Arenas JI; Hepatology Unit, University Hospital Donostia, San Sebastián, Spain.
García-Bujalance S; Clinical Microbiology Unit, University Hospital La Paz, Madrid, Spain.
Ríos MJ; Infectious Diseases Unit, University Hospital Virgen Macarena, Seville, Spain.
Bernal E; Infectious Diseases Unit, Hospital General Reina Sofía, Murcia, Spain.
Martínez O; Infectious Diseases Unit, University Hospital Santa Lucía, Cartagena, Spain.
García-Herola A; Hepatology Unit, Hospital Marina Baixa, Vilajoyosa, Alicante, Spain.
Vélez M; Infectious Diseases Unit, Hospital General de La Palma, La Palma, Spain.
Rincón P; Infectious Diseases Unit, University Hospital Nuestra Señora de Valme, Sevilla, Spain.
García F; Clinical Microbiology Unit, University Hospital San Cecilio, Instituto de Investigacion Ibs. Granada, Granada, Spain.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2019 Aug 30; Vol. 14 (8), pp. e0221231. Date of Electronic Publication: 2019 Aug 30 (Print Publication: 2019).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hepacivirus/*genetics
Hepatitis C, Chronic/*drug therapy
Viral Nonstructural Proteins/*genetics
Amides ; Antiviral Agents/adverse effects ; Antiviral Agents/therapeutic use ; Benzofurans/therapeutic use ; Carbamates ; Cyclopropanes ; Drug Resistance, Viral/genetics ; Female ; Genotype ; Hepacivirus/pathogenicity ; Hepatitis C, Chronic/epidemiology ; Hepatitis C, Chronic/genetics ; Hepatitis C, Chronic/virology ; Humans ; Imidazoles/therapeutic use ; Male ; Middle Aged ; Mutation ; Quinoxalines/therapeutic use ; Ribavirin/therapeutic use ; Sofosbuvir/therapeutic use ; Spain/epidemiology ; Sulfonamides ; Sustained Virologic Response

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients.
Autorzy:: Macías J; Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain.
Téllez F; Infectious Diseases and Microbiology Unit, Hospital Universitario de Puerto Real, Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz (INiBICA), Cadiz, Spain.
Rivero-Juárez A; Instituto Maimonides de Investigación Biomedica de Córdoba (IMIBIC), Hospital Universitario Reina Sofia, Cordoba, Spain.
Palacios R; Infectious Diseases, Microbiology and Preventive Medicine Unit, Hospital Universitario Virgen de la Victoria, Malaga, Spain.
Morano LE; Infectious Diseases Unit, Hospital Universitario Alvaro Cunqueiro, Vigo, Spain.
Merino D; Infectious Diseases Unit, Hospital Juan Ramón Jiménez, Huelva, Spain.
Collado A; Infectious Diseases Unit, Hospital Torrecárdenas, Almeria, Spain.
García-Fraile L; Infectious Diseases-Internal Medicine Service, Hospital Universitario de la Princesa, Madrid, Spain.
Omar M; Infectious Diseases Unit, Hospital de Jaen, Jaen, Spain.
Pineda JA; Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain.; Pokaż więcej
Corporate Authors:: the HEPAVIR, GEHEP and RIS-HEP07 study groups
Źródło:: Journal of viral hepatitis [J Viral Hepat] 2019 Jan; Vol. 26 (1), pp. 48-54. Date of Electronic Publication: 2018 Oct 17.
Typ publikacji:: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Antiviral Agents/*adverse effects
HIV Infections/*complications
HIV Infections/*drug therapy
Hepatitis C, Chronic/*drug therapy
Opportunistic Infections/*etiology
CD4 Lymphocyte Count ; Female ; HIV Infections/virology ; Humans ; Incidence ; Liver Cirrhosis ; Male ; Middle Aged ; Prospective Studies ; Retrospective Studies ; Sustained Virologic Response ; Treatment Outcome ; Virus Activation/drug effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort.
Autorzy:: Álvarez-Ossorio MJ; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.
Sarmento E Castro R; Unit of Infectious Diseases, Centro Hospitalar do Porto, Porto, Portugal.
Granados R; Unit of Infectious Diseases, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain.
Macías J; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.
Morano-Amado LE; Unit of Infectious Pathology, Hospital Universitario Alvaro Cunqueiro, Vigo, Spain.
Ríos MJ; Unit of Infectious Diseases, Hospital Universitario Virgen Macarena, Seville, Spain.
Merino D; Unit of Infectious Diseases, Complejo Hospitalario Universitario de Huelva, Huelva, Spain.
Álvarez EN; Infectious Diseases Unit, Hospital Universitario Virgen de la Victoria, Malaga, Spain.
Collado A; Infectious Diseases Unit, Hospital Universitario Torrecárdenas, Almeria, Spain.
Pérez-Pérez M; Unit of Infectious Diseases, Hospital La Línea, AGS Campo de Gibraltar, Cadiz, Spain.
Téllez F; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Puerto Real, Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz (INiBICA), Puerto Real, Spain.
Martín JM; Unit of Infectious Diseases, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain.
Méndez J; Unit of Infectious Diseases, Centro Hospitalar do Porto, Porto, Portugal.
Pineda JA; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.
Neukam K; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain.; Pokaż więcej
Corporate Authors:: HEPAVIR-DAA, GEHEP-MONO, RIS-HEP07 and RIS-HEP13 Study Groups
Źródło:: Journal of viral hepatitis [J Viral Hepat] 2018 Jun; Vol. 25 (6), pp. 699-706. Date of Electronic Publication: 2018 Feb 27.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Glomerular Filtration Rate*
Antiviral Agents/*administration & dosage
Antiviral Agents/*adverse effects
Hepatitis C, Chronic/*complications
Hepatitis C, Chronic/*drug therapy
2-Naphthylamine ; Anilides/administration & dosage ; Anilides/adverse effects ; Carbamates/administration & dosage ; Carbamates/adverse effects ; Cyclopropanes ; Female ; HIV Infections/complications ; HIV Infections/drug therapy ; Humans ; Lactams, Macrocyclic ; Macrocyclic Compounds/administration & dosage ; Macrocyclic Compounds/adverse effects ; Male ; Middle Aged ; Portugal ; Proline/analogs & derivatives ; Prospective Studies ; Retrospective Studies ; Spain ; Sulfonamides/administration & dosage ; Sulfonamides/adverse effects ; Treatment Outcome ; Uracil/administration & dosage ; Uracil/adverse effects ; Uracil/analogs & derivatives ; Valine

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.
Autorzy:: Macías J; Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain.
Monge P; Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain.
Mancebo M; Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain.
Merchante N; Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain.
Neukam K; Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain.
Real LM; Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain.
Pineda JA; Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain.; Pokaż więcej
Źródło:: HIV medicine [HIV Med] 2017 Aug; Vol. 18 (7), pp. 445-451. Date of Electronic Publication: 2016 Nov 24.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Drug Interactions*
Antiviral Agents/*therapeutic use
Coinfection/*drug therapy
HIV Infections/*complications
HIV Infections/*drug therapy
Hepatitis C, Chronic/*complications
Hepatitis C, Chronic/*drug therapy
Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Spain ; Tertiary Care Centers

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
Autorzy:: Núñez-Torres R; Unit of Infectious Diseases and Microbiology, Valme University Hospital, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain.
Macías J; Unit of Infectious Diseases and Microbiology, Valme University Hospital, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain.
Mancebo M; Unit of Infectious Diseases and Microbiology, Valme University Hospital, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain.
Frías M; Unit of Infectious Diseases, Reina Sofía University Hospital, Córdoba, Spain.; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBC), University of Córdoba, Córdoba, Spain.
Dolci G; Department of Medical and Surgical Science for Adults and Children, Clinic and Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
Téllez F; Unit of Infectious Diseases, La Línea de la Concepción Hospital, Cádiz, Spain.
Merino D; Unit of Infectious Diseases, Huelva University Hospital, Huelva, Spain.
Merchante N; Unit of Infectious Diseases and Microbiology, Valme University Hospital, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain.
Gómez-Mateos J; Unit of Infectious Diseases and Microbiology, Valme University Hospital, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain.
Guaraldi G; Department of Medical and Surgical Science for Adults and Children, Clinic and Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
Rivero-Juárez A; Unit of Infectious Diseases, Reina Sofía University Hospital, Córdoba, Spain.; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBC), University of Córdoba, Córdoba, Spain.
Pineda JA; Unit of Infectious Diseases and Microbiology, Valme University Hospital, Seville, Spain.
Real LM; Unit of Infectious Diseases and Microbiology, Valme University Hospital, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain.; Pokaż więcej
Corporate Authors:: HEPAVIR-esteatosis Study Group
Źródło:: PloS one [PLoS One] 2016 Dec 14; Vol. 11 (12), pp. e0168265. Date of Electronic Publication: 2016 Dec 14 (Print Publication: 2016).
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: HIV Infections/*genetics
HIV Infections/*physiopathology
Hepatitis C, Chronic/*genetics
Hepatitis C, Chronic/*physiopathology
Lipase/*genetics
Liver Cirrhosis/*genetics
Membrane Proteins/*genetics
Adult ; Alleles ; Coinfection/virology ; Cross-Sectional Studies ; Disease Progression ; Elasticity Imaging Techniques ; Fatty Liver/genetics ; Female ; Genetic Markers ; Genetic Variation ; Humans ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/virology ; Liver Transplantation ; Longitudinal Studies ; Male ; Middle Aged ; Multivariate Analysis ; Odds Ratio ; Polymorphism, Genetic ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection.
Autorzy:: Macías J; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Sevilla, Spain.
López-Cortés LF; Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain.
Téllez F; Unidad de Gestión Clínica de Enfermedades Infecciosas y Microbiología, Hospital de La Línea de la Concepción, AGS Campo de Gibraltar, Cádiz, Spain.
Recio E; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Sevilla, Spain.
Ojeda-Burgos G; Unidad de Gestión Clínica de Enfermedades Infecciosas, Hospital Virgen de la Victoria, Complejo Hospitalario de Málaga, Málaga, Spain.
Ríos MJ; Unidad de Enfermedades Infecciosas, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Rivero-Juárez A; Unidad de Enfermedades Infecciosas, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Delgado M; Servicio de Enfermedades Infecciosas, Hospital Regional de Málaga, Malaga, Spain.
Rivas-Jeremías; Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain.
Pineda JA; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Sevilla, Spain.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Dec 07; Vol. 10 (12), pp. e0143492. Date of Electronic Publication: 2015 Dec 07 (Print Publication: 2015).
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: HIV Infections/*complications
HIV Infections/*drug therapy
Hepatitis C, Chronic/*complications
Hepatitis C, Chronic/*drug therapy
Interferon-alpha/*administration & dosage
Polyethylene Glycols/*administration & dosage
Ribavirin/*administration & dosage
Thiazoles/*administration & dosage
Adult ; Antiviral Agents/administration & dosage ; Antiviral Agents/adverse effects ; Coinfection/drug therapy ; Drug Therapy, Combination ; Female ; Genotype ; Hepacivirus/classification ; Hepacivirus/genetics ; Hepacivirus/isolation & purification ; Hepatitis C, Chronic/virology ; Humans ; Interferon alpha-2 ; Interferon-alpha/adverse effects ; Male ; Middle Aged ; Nitro Compounds ; Pilot Projects ; Polyethylene Glycols/adverse effects ; RNA, Viral/blood ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/adverse effects ; Ribavirin/adverse effects ; Thiazoles/adverse effects ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians.
Autorzy:: Real LM; Unidad Clínica de Enfermedades Infecciosas y Microbiología. Hospital Universitario de Valme, Sevilla, Spain; Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain.
Neukam K; Unidad Clínica de Enfermedades Infecciosas y Microbiología. Hospital Universitario de Valme, Sevilla, Spain; Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain.
Herrero R; Unidad de Inmunogenética, Universidad de Jaén, Jaén, Spain.
Guardiola JM; Servicio de Medicina Interna. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Reiberger T; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna HIV & Liver Study Group, Vienna, Austria.
Rivero-Juarez A; Unidad de Enfermedades Infecciosas, Hospital Universitario Reina Sofía, Córdoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBC), Córdoba, Spain.
Salazar J; Servicio de Medicina Interna. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Mandorfer M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna HIV & Liver Study Group, Vienna, Austria.
Merino D; Unidad de Enfermedades Infecciosas. Hospital Juan Ramón Jiménez, Huelva, Spain.
Soriano V; Departamento de Enfermedades Infecciosas. Hospital Carlos III, Madrid, Spain.
Rivero A; Unidad de Enfermedades Infecciosas, Hospital Universitario Reina Sofía, Córdoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBC), Córdoba, Spain.
Macías J; Unidad Clínica de Enfermedades Infecciosas y Microbiología. Hospital Universitario de Valme, Sevilla, Spain; Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain.
Pineda JA; Unidad Clínica de Enfermedades Infecciosas y Microbiología. Hospital Universitario de Valme, Sevilla, Spain; Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain.
Caruz A; Unidad de Inmunogenética, Universidad de Jaén, Jaén, Spain.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2014 Apr 18; Vol. 9 (4), pp. e95515. Date of Electronic Publication: 2014 Apr 18 (Print Publication: 2014).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Alleles*
Genotype*
Antiviral Agents/*therapeutic use
Hepacivirus/*genetics
Hepatitis C, Chronic/*drug therapy
Hepatitis C, Chronic/*genetics
Interleukins/*genetics
Interleukins/*therapeutic use
Adult ; Coinfection ; Female ; Follow-Up Studies ; Hepatitis C, Chronic/virology ; Humans ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; ROC Curve ; Treatment Outcome ; White People/genetics